My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 630

    1.

    Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.

    Li Y, Xu W, Liao Z, Yao B, Chen X, Huang Z, Hu G, Weng J.

    Diabetes Care. 2004 Nov;27(11):2597-602.PMID: 15504992 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Influencing factors for the curative effects of short-term continuous subcutaneous insulin infusion on newly diagnosed type 2 diabetes]

    Li YB, Zhu HL, Yao B, Huang ZM, Ou XZ, Xiao YB, Weng JP.

    Zhonghua Yi Xue Za Zhi. 2005 Mar 9;85(9):602-5. Chinese. PMID: 15949356 [PubMed - indexed for MEDLINE]Related articles

    3.

    Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.

    Ilkova H, Glaser B, Tunçkale A, Bagriaçik N, Cerasi E.

    Diabetes Care. 1997 Sep;20(9):1353-6.PMID: 9283777 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

    Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H.

    Lancet. 2008 May 24;371(9626):1753-60.PMID: 18502299 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Characteristics of dysfunction of islet beta-cell in newly diagnosed type 2 diabetic patients]

    Li YB, Zhu DL, Tian HM, Shi LX, Luo ZJ, Yan L, Zeng LY, Zhou ZG, Yang LY, Liu J, Li M, Weng JP.

    Zhonghua Yi Xue Za Zhi. 2006 Sep 26;86(36):2537-41. Chinese. PMID: 17198561 [PubMed - indexed for MEDLINE]Related articles

    6.

    Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".

    Banerji MA.

    J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:493-501. Review.PMID: 12017222 [PubMed - indexed for MEDLINE]Related articles

    7.

    Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy.

    Chen HS, Wu TE, Jap TS, Hsiao LC, Lee SH, Lin HD.

    Diabetes Care. 2008 Oct;31(10):1927-32. Epub 2008 Jun 12.PMID: 18556343 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.

    McFarlane SI, Chaiken RL, Hirsch S, Harrington P, Lebovitz HE, Banerji MA.

    Diabet Med. 2001 Jan;18(1):10-6.PMID: 11168335 [PubMed - indexed for MEDLINE]Related articles

    9.

    A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.

    Yu JG, Kruszynska YT, Mulford MI, Olefsky JM.

    Diabetes. 1999 Dec;48(12):2414-21.PMID: 10580431 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Short-term intensive insulin therapy in newly diagnosed type 2 diabetes.

    Ryan EA, Imes S, Wallace C.

    Diabetes Care. 2004 May;27(5):1028-32.PMID: 15111515 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.

    Festa A, Williams K, Hanley AJ, Haffner SM.

    Diabetes. 2008 Jun;57(6):1638-44. Epub 2008 Mar 10.PMID: 18332099 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes.

    Glaser B, Leibovich G, Nesher R, Hartling S, Binder C, Cerasi E.

    Acta Endocrinol (Copenh). 1988 Jul;118(3):365-73.PMID: 3293339 [PubMed - indexed for MEDLINE]Related articles

    13.

    Induction of long-term normoglycemia without medication in Korean type 2 diabetes patients after continuous subcutaneous insulin infusion therapy.

    Park S, Choi SB.

    Diabetes Metab Res Rev. 2003 Mar-Apr;19(2):124-30.PMID: 12673780 [PubMed - indexed for MEDLINE]Related articles

    14.

    Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.

    Quddusi S, Vahl TP, Hanson K, Prigeon RL, D'Alessio DA.

    Diabetes Care. 2003 Mar;26(3):791-8.PMID: 12610039 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.

    Degn KB, Juhl CB, Sturis J, Jakobsen G, Brock B, Chandramouli V, Rungby J, Landau BR, Schmitz O.

    Diabetes. 2004 May;53(5):1187-94.PMID: 15111485 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus]

    Liu J, Li YB, Shao H, Li YX, Yuan YH, Xiao YB, Weng JP.

    Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1252-5. Chinese. PMID: 17686259 [PubMed - indexed for MEDLINE]Related articles

    17.

    Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance.

    Taha D, Umpaichitra V, Banerji MA, Castells S.

    J Pediatr Endocrinol Metab. 2006 Feb;19(2):135-42.PMID: 16562586 [PubMed - indexed for MEDLINE]Related articles

    18.

    A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

    DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ; Dutch Insulin Pump Study Group.

    Diabetes Care. 2002 Nov;25(11):2074-80.PMID: 12401759 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The significance of tumor necrosis factor-alpha in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.

    Chen H, Ren A, Hu S, Mo W, Xin X, Jia W.

    Diabetes Res Clin Pract. 2007 Mar;75(3):327-32. Epub 2006 Aug 22.PMID: 16930761 [PubMed - indexed for MEDLINE]Related articles

    20.

    Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.

    Amoah AG, Owusu SK, Schuster DP, Osei K.

    S Afr Med J. 2002 May;92(5):377-84.PMID: 12108171 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity